Due to the famous obfuscation of their reporting I did not know it was this bad. When Kotsanis was hired he was supposed to be a world authority on generic medicines.
How can it be that everything that was chosen for development has been a flop? Each choice was made, we are told after a thorough analysis, careful selection and with the input of experts.
I am scratching my head trying to understand how we got here. Michael Kotsanis should have the decency to resign given his consistant and unrelenting failure to deliver success for shareholders. You can’t say he has not been given long enough to see his plans through. His is the ultimate triumph of hope over experience and my money is gone because of it.
Time to do the right thing.
Add to My Watchlist
What is My Watchlist?
